Dates: 01/06/2018
31/05/2023


Topic: Biomarkers identification
Procedures


Project type: Preclinic
Clinic


Project target: Neurology


Financing:

H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME
H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2)
Other


Participating agents:

KING’S COLLEGE LONDON


Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium


Countries: UK; Switzerland; Netherlands; Spain; France; Germany; Belgium; France; Ireland; Sweden; Italy; South Africa; Portugal; Israel; USA


Project page: Access page

 

Leave a Reply

Your email address will not be published. Required fields are marked *